Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1210 entries
Sorted by: Best Match Show Resources per page
[Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)].

Wiener klinische Wochenschrift

Mutz ID, Urban CE.
PMID: 741754
Wien Klin Wochenschr. 1978 Dec 22;90(24):867-70.

Eight children with state III or IV neuroblastoma were treated with courses of chemotherapy consisting of nitrogen mustard (6 mg/m2), vincristine (2 X 1.5 mg/m2), doxorubicin (40 mg/m2) and dimethyl-triazeno-imidazolecarboxamide (850 mg/m2) every three weeks. Three children died after...

Cite
Mutz ID, Urban CE. Chemotherapie bei Neuroblastom im Kindesalter mit einer Dimethyl-Triazeno-Imidazol-Carboxamid-(DTIC-)Kombination. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)]. Wien Klin Wochenschr. 1978;90(24):867-70
Mutz, I. D., & Urban, C. E. (1978). Chemotherapie bei Neuroblastom im Kindesalter mit einer Dimethyl-Triazeno-Imidazol-Carboxamid-(DTIC-)Kombination. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)]. Wiener klinische Wochenschrift, 90(24), 867-70.
Mutz, I D, and Urban, C E. "Chemotherapie bei Neuroblastom im Kindesalter mit einer Dimethyl-Triazeno-Imidazol-Carboxamid-(DTIC-)Kombination." [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)]. Wiener klinische Wochenschrift vol. 90,24 (1978): 867-70.
Mutz ID, Urban CE. Chemotherapie bei Neuroblastom im Kindesalter mit einer Dimethyl-Triazeno-Imidazol-Carboxamid-(DTIC-)Kombination. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)]. Wien Klin Wochenschr. 1978 Dec 22;90(24):867-70. German. PMID: 741754.
Copy Download .nbib Format: NLM
Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor.

Pediatric hematology and oncology

Emminger W, Gadner H.
PMID: 1356004
Pediatr Hematol Oncol. 1992 Apr-Jun;9(2):183-5. doi: 10.3109/08880019209018336.

No abstract available.

Cite
Emminger W, Gadner H. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor. Pediatr Hematol Oncol. 1992;9(2):183-5doi: 10.3109/08880019209018336.
Emminger, W., & Gadner, H. (1992). Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor. Pediatric hematology and oncology, 9(2), 183-5. https://doi.org/10.3109/08880019209018336
Emminger, W, and Gadner, H. "Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor." Pediatric hematology and oncology vol. 9,2 (1992): 183-5. doi: https://doi.org/10.3109/08880019209018336
Emminger W, Gadner H. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor. Pediatr Hematol Oncol. 1992 Apr-Jun;9(2):183-5. doi: 10.3109/08880019209018336. PMID: 1356004.
Copy Download .nbib Format: NLM
Survival trends for neuroblastoma patients in Finland: negative reflections on screening.

European journal of cancer (Oxford, England : 1990)

Sankila R, Hakama M.
PMID: 1445728
Eur J Cancer. 1992;29(1):122-3. doi: 10.1016/0959-8049(93)90588-7.

Based on 257 neuroblastoma patients in the age group 0-14 years and reported to the Finnish Cancer Registry, the 5-year cumulative survival rates have improved from 15% in the 1950s to 57% in 1980-1986. The potential benefit of screening...

Cite
Sankila R, Hakama M. Survival trends for neuroblastoma patients in Finland: negative reflections on screening. Eur J Cancer. 1992;29(1):122-3doi: 10.1016/0959-8049(93)90588-7.
Sankila, R., & Hakama, M. (1992). Survival trends for neuroblastoma patients in Finland: negative reflections on screening. European journal of cancer (Oxford, England : 1990), 29(1), 122-3. https://doi.org/10.1016/0959-8049(93)90588-7
Sankila, R, and Hakama, M. "Survival trends for neuroblastoma patients in Finland: negative reflections on screening." European journal of cancer (Oxford, England : 1990) vol. 29,1 (1992): 122-3. doi: https://doi.org/10.1016/0959-8049(93)90588-7
Sankila R, Hakama M. Survival trends for neuroblastoma patients in Finland: negative reflections on screening. Eur J Cancer. 1992;29(1):122-3. doi: 10.1016/0959-8049(93)90588-7. PMID: 1445728.
Copy Download .nbib Format: NLM
Features and outcome of advanced neuroblastoma with distant lymph node metastasis.

Pediatric hematology and oncology

Yamada S, Ishii E, Nakagawara A, Akazawa K, Tasaka H, Kajiwara M, Kawakami K, Ueda K.
PMID: 1558776
Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):49-56. doi: 10.3109/08880019209006396.

We examined 52 children with advanced neuroblastoma who were diagnosed and treated during the past 7 years, and investigated the correlation between the degree of lymph node (LN) metastasis and the prognosis of neuroblastoma. In 8 of the 52...

Cite
Yamada S, Ishii E, Nakagawara A, et al. Features and outcome of advanced neuroblastoma with distant lymph node metastasis. Pediatr Hematol Oncol. 1992;9(1):49-56doi: 10.3109/08880019209006396.
Yamada, S., Ishii, E., Nakagawara, A., Akazawa, K., Tasaka, H., Kajiwara, M., Kawakami, K., & Ueda, K. (1992). Features and outcome of advanced neuroblastoma with distant lymph node metastasis. Pediatric hematology and oncology, 9(1), 49-56. https://doi.org/10.3109/08880019209006396
Yamada, S, et al. "Features and outcome of advanced neuroblastoma with distant lymph node metastasis." Pediatric hematology and oncology vol. 9,1 (1992): 49-56. doi: https://doi.org/10.3109/08880019209006396
Yamada S, Ishii E, Nakagawara A, Akazawa K, Tasaka H, Kajiwara M, Kawakami K, Ueda K. Features and outcome of advanced neuroblastoma with distant lymph node metastasis. Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):49-56. doi: 10.3109/08880019209006396. PMID: 1558776.
Copy Download .nbib Format: NLM
Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.

Cancer

De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, Corciulo P, Mancini A, De Laurentis C, Di Tullio MT.
PMID: 1516016
Cancer. 1992 Sep 15;70(6):1625-33. doi: 10.1002/1097-0142(19920915)70:6<1625::aid-cncr2820700631>3.0.co;2-6.

BACKGROUND: Infants (age 0-11 months) with disseminated neuroblastoma are known to have a better prognosis than older children with the disease, but there is little information regarding factors that influence the outcome of the disease in these patients.METHODS: The...

Cite
De Bernardi B, Pianca C, Boni L, et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer. 1992;70(6):1625-33doi: 10.1002/1097-0142(19920915)70:6<1625::aid-cncr2820700631>3.0.co;2-6.
De Bernardi, B., Pianca, C., Boni, L., Brisigotti, M., Carli, M., Bagnulo, S., Corciulo, P., Mancini, A., De Laurentis, C., & Di Tullio, M. T. (1992). Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer, 70(6), 1625-33. https://doi.org/10.1002/1097-0142(19920915)70:6<1625::aid-cncr2820700631>3.0.co;2-6
De Bernardi, B, et al. "Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma." Cancer vol. 70,6 (1992): 1625-33. doi: https://doi.org/10.1002/1097-0142(19920915)70:6<1625::aid-cncr2820700631>3.0.co;2-6
De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, Corciulo P, Mancini A, De Laurentis C, Di Tullio MT. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer. 1992 Sep 15;70(6):1625-33. doi: 10.1002/1097-0142(19920915)70:6<1625::aid-cncr2820700631>3.0.co;2-6. PMID: 1516016.
Copy Download .nbib Format: NLM
Significance of catecholamine excretion in the follow-up of sympathoblastomas.

Cancer

Barontini de Gutiérrez, Bergadá C, Becú L.
PMID: 4321900
Cancer. 1971 Jan;27(1):228-32. doi: 10.1002/1097-0142(197101)27:1<228::aid-cncr2820270132>3.0.co;2-f.

No abstract available.

Cite
Barontini de Gutiérrez, Bergadá C, Becú L. Significance of catecholamine excretion in the follow-up of sympathoblastomas. Cancer. 1971;27(1):228-32doi: 10.1002/1097-0142(197101)27:1<228::aid-cncr2820270132>3.0.co;2-f.
Barontini de Gutiérrez, Bergadá, C., & Becú, L. (1971). Significance of catecholamine excretion in the follow-up of sympathoblastomas. Cancer, 27(1), 228-32. https://doi.org/10.1002/1097-0142(197101)27:1<228::aid-cncr2820270132>3.0.co;2-f
Barontini de Gutiérrez, et al. "Significance of catecholamine excretion in the follow-up of sympathoblastomas." Cancer vol. 27,1 (1971): 228-32. doi: https://doi.org/10.1002/1097-0142(197101)27:1<228::aid-cncr2820270132>3.0.co;2-f
Barontini de Gutiérrez, Bergadá C, Becú L. Significance of catecholamine excretion in the follow-up of sympathoblastomas. Cancer. 1971 Jan;27(1):228-32. doi: 10.1002/1097-0142(197101)27:1<228::aid-cncr2820270132>3.0.co;2-f. PMID: 4321900.
Copy Download .nbib Format: NLM
The multiple manifestations of neuroblastoma.

The Journal of urology

Donohue JP, Garrett RA, Baehner RL, Thomas MH.
PMID: 4810777
J Urol. 1974 Feb;111(2):260-4. doi: 10.1016/s0022-5347(17)59942-5.

No abstract available.

Cite
Donohue JP, Garrett RA, Baehner RL, et al. The multiple manifestations of neuroblastoma. J Urol. 1974;111(2):260-4doi: 10.1016/s0022-5347(17)59942-5.
Donohue, J. P., Garrett, R. A., Baehner, R. L., & Thomas, M. H. (1974). The multiple manifestations of neuroblastoma. The Journal of urology, 111(2), 260-4. https://doi.org/10.1016/s0022-5347(17)59942-5
Donohue, J P, et al. "The multiple manifestations of neuroblastoma." The Journal of urology vol. 111,2 (1974): 260-4. doi: https://doi.org/10.1016/s0022-5347(17)59942-5
Donohue JP, Garrett RA, Baehner RL, Thomas MH. The multiple manifestations of neuroblastoma. J Urol. 1974 Feb;111(2):260-4. doi: 10.1016/s0022-5347(17)59942-5. PMID: 4810777.
Copy Download .nbib Format: NLM
[Early diagnosis of cancer in children].

Anales espanoles de pediatria

Esquembre Menor CT, Castel Sánchez V.
PMID: 3074700
An Esp Pediatr. 1988 Sep;29:181-7.

No abstract available.

Cite
Esquembre Menor CT, Castel Sánchez V. Diagnóstico precoz del cáncer infantil. [Early diagnosis of cancer in children]. An Esp Pediatr. 1988;29:181-7
Esquembre Menor, C. T., & Castel Sánchez, V. (1988). Diagnóstico precoz del cáncer infantil. [Early diagnosis of cancer in children]. Anales espanoles de pediatria, 29181-7.
Esquembre Menor, C T, and Castel Sánchez, V. "Diagnóstico precoz del cáncer infantil." [Early diagnosis of cancer in children]. Anales espanoles de pediatria vol. 29 (1988): 181-7.
Esquembre Menor CT, Castel Sánchez V. Diagnóstico precoz del cáncer infantil. [Early diagnosis of cancer in children]. An Esp Pediatr. 1988 Sep;29:181-7. Spanish. PMID: 3074700.
Copy Download .nbib Format: NLM
Tumour karyotype may be important in the prognosis of human neuroblastoma.

Journal of cancer research and clinical oncology

Franke F, Rudolph B, Christiansen H, Harbott J, Lampert F.
PMID: 3733856
J Cancer Res Clin Oncol. 1986;111(3):266-72. doi: 10.1007/BF00389243.

When comparing clinical and tumour cytogenetic data on 14 neuroblastoma patients in different stages of disease we found a high incidence of 1p abnormalities (12/12), homogeneously staining regions/double minutes (9/12) and 2p abnormalities (4/12) in 12 unresectable and metastatic...

Cite
Franke F, Rudolph B, Christiansen H, et al. Tumour karyotype may be important in the prognosis of human neuroblastoma. J Cancer Res Clin Oncol. 1986;111(3):266-72doi: 10.1007/BF00389243.
Franke, F., Rudolph, B., Christiansen, H., Harbott, J., & Lampert, F. (1986). Tumour karyotype may be important in the prognosis of human neuroblastoma. Journal of cancer research and clinical oncology, 111(3), 266-72. https://doi.org/10.1007/BF00389243
Franke, F, et al. "Tumour karyotype may be important in the prognosis of human neuroblastoma." Journal of cancer research and clinical oncology vol. 111,3 (1986): 266-72. doi: https://doi.org/10.1007/BF00389243
Franke F, Rudolph B, Christiansen H, Harbott J, Lampert F. Tumour karyotype may be important in the prognosis of human neuroblastoma. J Cancer Res Clin Oncol. 1986;111(3):266-72. doi: 10.1007/BF00389243. PMID: 3733856.
Copy Download .nbib Format: NLM
The extra-adrenal neuroblastoma: high radiocurability and diagnostic accuracy.

The American journal of roentgenology, radium therapy, and nuclear medicine

Young LW, Rubin P, Hanson RE.
PMID: 4188902
Am J Roentgenol Radium Ther Nucl Med. 1970 Jan;108(1):75-91. doi: 10.2214/ajr.108.1.75.

No abstract available.

Cite
Young LW, Rubin P, Hanson RE. The extra-adrenal neuroblastoma: high radiocurability and diagnostic accuracy. Am J Roentgenol Radium Ther Nucl Med. 1970;108(1):75-91doi: 10.2214/ajr.108.1.75.
Young, L. W., Rubin, P., & Hanson, R. E. (1970). The extra-adrenal neuroblastoma: high radiocurability and diagnostic accuracy. The American journal of roentgenology, radium therapy, and nuclear medicine, 108(1), 75-91. https://doi.org/10.2214/ajr.108.1.75
Young, L W, et al. "The extra-adrenal neuroblastoma: high radiocurability and diagnostic accuracy." The American journal of roentgenology, radium therapy, and nuclear medicine vol. 108,1 (1970): 75-91. doi: https://doi.org/10.2214/ajr.108.1.75
Young LW, Rubin P, Hanson RE. The extra-adrenal neuroblastoma: high radiocurability and diagnostic accuracy. Am J Roentgenol Radium Ther Nucl Med. 1970 Jan;108(1):75-91. doi: 10.2214/ajr.108.1.75. PMID: 4188902.
Copy Download .nbib Format: NLM
Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.

European journal of pediatrics

Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
PMID: 3391225
Eur J Pediatr. 1988 Apr;147(3):308-11. doi: 10.1007/BF00442702.

Sixty-eight cases of neuroblastoma detected during mass screening being performed by 11 local self-governing bodies of Japan were studied concerning age, clinical stage, and survival rate. Their average ages at the first screening, at the beginning of thorough examination,...

Cite
Nishi M, Miyake H, Takeda T, et al. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. Eur J Pediatr. 1988;147(3):308-11doi: 10.1007/BF00442702.
Nishi, M., Miyake, H., Takeda, T., Takasugi, N., Sato, Y., & Hanai, J. (1988). Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. European journal of pediatrics, 147(3), 308-11. https://doi.org/10.1007/BF00442702
Nishi, M, et al. "Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases." European journal of pediatrics vol. 147,3 (1988): 308-11. doi: https://doi.org/10.1007/BF00442702
Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. Eur J Pediatr. 1988 Apr;147(3):308-11. doi: 10.1007/BF00442702. PMID: 3391225.
Copy Download .nbib Format: NLM
Exfoliative cytology of metastatic neuroblastoma.

Acta cytologica

Farr GH, Hajdu SI.
PMID: 4503068
Acta Cytol. 1972 May-Jun;16(3):203-6.

No abstract available.

Cite
Farr GH, Hajdu SI. Exfoliative cytology of metastatic neuroblastoma. Acta Cytol. 1972;16(3):203-6
Farr, G. H., & Hajdu, S. I. (1972). Exfoliative cytology of metastatic neuroblastoma. Acta cytologica, 16(3), 203-6.
Farr, G H, and Hajdu, S I. "Exfoliative cytology of metastatic neuroblastoma." Acta cytologica vol. 16,3 (1972): 203-6.
Farr GH, Hajdu SI. Exfoliative cytology of metastatic neuroblastoma. Acta Cytol. 1972 May-Jun;16(3):203-6. PMID: 4503068.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1210 entries